Pfizer Launches Clinical Trial Testing its COVID-19 Pill in Children Aged 6 and Older

Pfizer announced Wednesday it is launching a clinical trial to study the effectiveness of its COVID-19 antiviral pill in young children. The treatment, Paxlovid, was authorized in December 2020 by the U.S. Food and Drug Administration for emergency use in patients aged 12 and older who have mild-to-moderate symptoms and are at increased risk of severe illness. Great!

Read more about it

Photo Credit: Brett Jordan